vimarsana.com
Home
Live Updates
Dr Jhaveri on the Implications of Treatment With RLY-2608 in Advanced ER+ Breast Cancer : comparemela.com
Dr Jhaveri on the Implications of Treatment With RLY-2608 in Advanced ER+ Breast Cancer
Komal Jhaveri, MD, FACP, discusses the implications of investigating treatment with RLY-2608 in patients with PIK3CA-mutant advanced ER+ breast cancer.
Related Keywords
Komal Jhaveri ,
James Cayne ,
Endocrine Therapy Research Program ,
Memorial Sloan Kettering Cancer Center ,
Early Drug Development Service ,
James Cayne Chair ,
Junior Faculty ,
comparemela.com © 2020. All Rights Reserved.